Posts

BioNTech and DualityBio team up to develop ADC therapeu...

Once developed, the ADCs will join BioNTech’s existing portfolio of oncology pro...

Innate Pharma and Takeda sign licence deal to develop A...

Innate will receive royalties on possible net sales of any commercial product to...

HUTCHMED concludes FDA rolling submission for colorecta...

The NDA submission is supported by data from the Phase III FRESCO and FRESCO-2 t...

Latest WHO Covid-19 vaccine guidance may decrease futur...

SAGE also updated its guidance on bivalent Covid-19 vaccines, now recommending t...

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi a...

The CHMP’s positive opinion was based on the data obtained from the pivotal Phas...

Eisai and National Cancer Center partner for tazemetost...

Eisai will be responsible for providing tazemetostat to the National Cancer Cent...

STAT+: FTC tells Illumina to divest Grail, boosting Ica...

The U.S. Federal Trade Commission on Monday ordered DNA sequencing giant Illumin...

STAT+: A young boy’s nightmare diagnosis, and the $3 mi...

Bluebird's Skysona gene therapy is expected to save the lives of patients with t...

STAT+: Vertex, CRISPR Therapeutics inch ahead of rival ...

Vertex Pharmaceuticals and its partner CRISPR Therapeutics said they had met the...

Why the early tests of ChatGPT in medicine miss the mark

Stanford researchers asked GPT-4 questions about real-life medical situations. T...

STAT+: A devastating skin condition could soon get its ...

B-VEC — which is dripped onto wounds from a syringe — would be the first topical...

STAT+: The biotech scorecard for the second quarter: 24...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech eve...

Opinion: Emergency rooms need clear guidelines about ho...

Emergency medicine workers need guidance on what to do when a police officer ref...

‘If we don’t, others will’: White House Covid adviser c...

Ashish Jha called on doctors to battle medical misinformation and disinformation...

STAT+: Pharmalittle: FDA slams company recalling eye dr...

Good morning, everyone, and welcome to another working week. We hope the weekend...

STAT+: Biden administration goes easy on Medicare Advan...

The Biden administration is going easy on Medicare Advantage insurers, after an ...